340B HRSA Listed Pharmacy License - Hillsborough County, Florida

This established pharmacy license presents a strategic acquisition opportunity for qualified buyers seeking entry into Florida's pharmaceutical market. The license comes from a continuously operating pharmacy with over one year of established operations and maintains clean regulatory standing.

Business Highlights:
- Active 340B HRSA program participation status
- Clean pharmacy license with established compliance record
- Relocatable within Hillsborough County jurisdiction
- No existing operational obligations or inventory transfers

The 340B Drug Pricing Program designation represents significant value, enabling participating pharmacies to purchase covered outpatient drugs at substantially discounted rates. This federal program serves safety-net healthcare providers including federally qualified health centers, disproportionate share hospitals, and other eligible entities, creating enhanced profit margins on qualifying prescriptions.

Market Opportunity:
Hillsborough County encompasses Tampa and surrounding areas with a population exceeding 1.4 million residents. The region demonstrates strong demographic diversity and continued population growth, supporting robust demand for pharmaceutical services across multiple patient segments.

Operational Advantages:
The license-only structure eliminates complexities associated with existing staff, inventory management, lease obligations, and customer transitions. Buyers gain immediate regulatory authorization to establish pharmacy operations at their preferred location within the county.

The current owner's decision to pursue alternative business models creates this opportunity for strategic buyers to acquire valuable pharmaceutical licensing with established 340B program benefits.

Investment Details:
Asking Price: $100,000
Location: Hillsborough County, Florida
Status: Relocatable license

This acquisition provides immediate access to Florida's pharmaceutical market with built-in competitive advantages through 340B program participation.